Investing.com - Oramed announced fourth quarter earnings that missed analysts' expectations on Wednesday and revenue that fell short of forecasts.
The company reported earnings per share of $-0.27 on revenue of $674.0K. Analysts polled by Investing.com anticipated EPS of $-0.24 on revenue of $700K. .
Oramed stock's are down 35.99% since the start of the year , down-from-52-week-high.
Oramed follows other major Healthcare sector earnings this month
On Thursday, August 4, 2022, Eli Lilly reported second quarter EPS of $1.25 on revenue of $6.49B, was in comparison with a forecasts for EPS of $1.7 on revenue of $6.85B.
Pfizer earnings beat analysts' expectations on Thursday, July 28, 2022, with second quarter EPS of $2.04 on revenue of $27.74B. Investing.com analysts anticipated EPS of $1.72 on revenue of $25.49B
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar